Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (151-160 of 239) with videos related to

Pageof 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1983
Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cellsT F Tedder, D T Fearon, G L Gartland, et al.
The Journal of Experimental Medicine|November 1, 1979
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bM D Kazatchkine, D T Fearon, J E Silbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cellsAlice E Denton, Edward W Roberts, Michelle A Linterman, et al.
The New England Journal of Medicine|April 10, 1986
Neutrophil activation in thermal injury as assessed by increased expression of complement receptorsF D Moore, C Davis, M Rodrick, et al.
The Journal of Clinical Investigation|April 1, 1982
Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosusM D Kazatchkine, D T Fearon, M D Appay, et al.
Science (New York, N.Y.)|January 19, 1996
C3d of complement as a molecular adjuvant: bridging innate and acquired immunityP W Dempsey, M E Allison, S Akkaraju, et al.
Complement (Basel, Switzerland)|January 1, 1986
Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritisM H Jouvin, J G Wilson, P Bourgeois, et al.
The Journal of Experimental Medicine|January 1, 1996
A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitorsA Rolink, E ten Boekel, F Melchers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycanJ G Wilson, D T Fearon, R L Stevens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1982
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement systemA Nicholson-Weller, J Burge, D T Fearon, et al.
Pageof 24

Showing results (151-160 of 239) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1983
Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cellsT F Tedder, D T Fearon, G L Gartland, et al.
The Journal of Experimental Medicine|November 1, 1979
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bM D Kazatchkine, D T Fearon, J E Silbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cellsAlice E Denton, Edward W Roberts, Michelle A Linterman, et al.
The New England Journal of Medicine|April 10, 1986
Neutrophil activation in thermal injury as assessed by increased expression of complement receptorsF D Moore, C Davis, M Rodrick, et al.
The Journal of Clinical Investigation|April 1, 1982
Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosusM D Kazatchkine, D T Fearon, M D Appay, et al.
Science (New York, N.Y.)|January 19, 1996
C3d of complement as a molecular adjuvant: bridging innate and acquired immunityP W Dempsey, M E Allison, S Akkaraju, et al.
Complement (Basel, Switzerland)|January 1, 1986
Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritisM H Jouvin, J G Wilson, P Bourgeois, et al.
The Journal of Experimental Medicine|January 1, 1996
A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitorsA Rolink, E ten Boekel, F Melchers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycanJ G Wilson, D T Fearon, R L Stevens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1982
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement systemA Nicholson-Weller, J Burge, D T Fearon, et al.
Pageof 24